Population Assessment of Tobacco and Health (PATH) Study [United States] Master Linkage Files

The PATH Study was launched in 2011 to inform the Food and Drug Administration's regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study sampled over 150,000 mailing addresses across the United States to create a national sample of those who do and do not use tobacco. 45,971 adults and youth constitute the first (baseline) wave, Wave 1, of data collected by this longitudinal cohort study. These 45,971 adults and youth along with 7,207 "shadow youth" (youth ages 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete the Youth Interview after parental consent. At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled Primary Sampling Units (PSUs) and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort. Please refer to the Restricted-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1 and Wave 4 Cohorts. Dataset 0001 (DS0001) contains the data from the Public-Use File Master Linkage File (PUF-MLF). This file contains 77 variables and 67,276 cases. The file provides a master list of every person's unique identification number and what type of respondent they were in each wave for data that are available in the Public-Use Files and Special Collection Public-Use Files. Dataset 0002 (DS0002) contains the data from the Restricted-Use File Master Linkage File (RUF-MLF). This file contains 158 variables and 67,276 cases. The file provides a master list of every person's unique identification number and what type of respondent they were in each wave for data that are available in the Restricted-Use Files, Special Collection Restricted-Use Files, and Biomarker Restricted-Use Files.

PATH 研究，自2011年起启动，旨在为食品药品监督管理局（FDA）根据《家庭吸烟预防与烟草控制法案》（TCA）进行的监管活动提供信息。PATH 研究（PATH Study）是由国家药物滥用研究所（NIDA）、国家卫生研究院（NIH）和食品药品监督管理局（FDA）下属的烟草产品中心（CTP）共同合作的一项研究。该研究在美国全国范围内选取了超过15万个邮寄地址，以构建一个全国性的样本，涵盖使用和不使用烟草的人群。其中，45,971名成人和青少年构成了该纵向队列研究的首次（基线）数据收集波次，即波次1。这45,971名成人和青少年以及7,207名“影子青少年”（在波次1中选取的9至11岁青少年）共同组成了53,178名参与者的波次1队列。受访者被要求在每一次后续波次完成一次访谈。在当前数据收集波次中达到18岁的青少年被视为“成年化青少年”，并受邀完成成人访谈。此外，"影子青少年"在12岁时被视为“成年化青少年”，在获得家长同意后，他们需要完成青少年访谈。在波次4中，从波次4时的平民、非机构化人群中选取了14,098名成人、青少年和10至11岁的“影子青少年”作为概率样本。此样本来自未被选中参与波次1的相同抽样初级抽样单位（PSUs）和分段，并采用类似的户内抽样程序进行招募。这个“补充样本”在估计和分析目的上与波次4的来自波次1队列的平民、非机构化成人及青少年受访者相结合。这个组合的波次4参与者总数达到52,731人，构成了波次4队列。请参阅限制性使用文件用户指南，以获取有关被指定为“影子青少年”的儿童以及波次1和波次4队列形成的更多详细信息。数据集0001（DS0001）包含来自公共使用文件主链接文件（PUF-MLF）的数据。该文件包含77个变量和67,276个案例。该文件提供了每个人员的唯一识别号码以及在每个波次中他们作为何种类型受访者的主列表，这些数据可在公共使用文件和特别收集公共使用文件中找到。数据集0002（DS0002）包含来自限制性使用文件主链接文件（RUF-MLF）的数据。该文件包含158个变量和67,276个案例。该文件提供了每个人员的唯一识别号码以及在每个波次中他们作为何种类型受访者的主列表，这些数据可在限制性使用文件、特别收集限制性使用文件和生物标志物限制性使用文件中找到。